Back

RESIST Trial: Role of Statin and Aspirin in SARS-CoV-2 Infection

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Latest Science in COVID-19 Lipid-Lowering Agents ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Deepti Siddharthan

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

5 More presentations in this session

Presentation thumbnail
Acute and chronic myocardial injury in patients with COVID-19
Doctor A. Kini (New York, US)
Slides Video
Presentation thumbnail
Hospitalized patients with hypertension and moderate COVID-19 benefit from continuing ACEIs and ARBs: Insights from the BRACE CORONA trial
Doctor A. Macedo (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Cardiovascular Risk Factors and COVID19 Risk
Doctor D. Leong (Hamilton, CA)
Slides Video
Presentation thumbnail
Intentional Weight Loss and COVID-19
Doctor A. Aminian (Cleveland, US)
Slides Video
Presentation thumbnail
The HEP-COVID Trial
Professor A. Spyropoulos (New York, US)
Slides Video

Access the full session

Session thumbnail
Latest Science in COVID-19

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources